| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 09/22/2004 | EP1458372A1 Calcium l-threonate for preventing or treating cartilage related diseases |
| 09/22/2004 | EP1458371A1 Pyruvate cardioplegia solutions for administration to the heart during cardiopulmonary surgery and methods of use thereof |
| 09/22/2004 | EP1458370A1 Treatment of faecal incontinence and other conditions with 1r,2s-methoxamine |
| 09/22/2004 | EP1458369A1 Gel comprising at least a retinoid and benzoyl peroxide |
| 09/22/2004 | EP1458368A1 Use of norepinephrine reuptake inhibitors for the treatment of cognitive failure |
| 09/22/2004 | EP1458365A1 Improved polymer-lipid delivery vehicles |
| 09/22/2004 | EP1458364A1 Pharmaceutical compositions comprising metformine and glibenclamide for the treatment of type-ii diabetes mellitus |
| 09/22/2004 | EP1458363A1 Pre-formulation for the tabletting of natural mixtures of conjugated estrogens |
| 09/22/2004 | EP1458362A2 Pharmaceutical compositions in particulate form |
| 09/22/2004 | EP1458361A2 Compositions for sustained action product delivery |
| 09/22/2004 | EP1458360A1 Pulmonary delivery of aminoglycosides |
| 09/22/2004 | EP1458358A1 Stable topical formulation of clarithromycin |
| 09/22/2004 | EP1458356A1 Micronized pharmaceutical or nutraceutical powder with immediate release |
| 09/22/2004 | EP1458355A2 Aqueous based pharmaceutical formulations of water-soluble prodrugs of propofol |
| 09/22/2004 | EP1458353A1 Formulation dosage form for the controlled delivery of ther apeutic agents |
| 09/22/2004 | EP1458349A1 Composition comprising at least an oxazolin for inhibiting langerhans cell migration, and uses thereof |
| 09/22/2004 | EP1458347A2 Composition comprising at least an alkanolamide for inhibiting langerhans cell migration, and uses thereof |
| 09/22/2004 | EP1458342A1 Cosmetic and dermatological light-protective formulations comprising hydroxybenzophenones and benzoxazole derivatives |
| 09/22/2004 | EP1458337A1 Stable surfactant compositions for suspending components |
| 09/22/2004 | EP1458234A1 Disruption of the prostaglandin e synthase 2 gene |
| 09/22/2004 | EP1414297A4 Sodium dodecyl sulfate compositions for inactivating prions |
| 09/22/2004 | EP1408876A4 Zero-order prolonged release coaxial implants |
| 09/22/2004 | EP1408755A4 Treatment for dry mouth employing carbamide peroxide |
| 09/22/2004 | EP1373298B1 A composition containing novel compound corniculatonin having antifungi properties and a process for preparing the same |
| 09/22/2004 | EP1305034A4 Methods of producing weight loss and treatment of obesity |
| 09/22/2004 | EP1289505B1 Process of producing a stable pharmaceutical composition containing micronized formoterol |
| 09/22/2004 | EP1280788B1 Method for the production of l-ascorbic acid by lactonisation of 2-keto-l-gulonic acid or 2-keto-l-gulonate esters |
| 09/22/2004 | EP1274709B1 Salts of bicyclic, n-acylated imidazo-3-amines and imidazo-5-amines |
| 09/22/2004 | EP1268475B1 Novel benzosultam oxazolidinone antibacterial agents |
| 09/22/2004 | EP1268389B1 Halogenated triphenylethylene derivatives as selective estrogen receptor modulators |
| 09/22/2004 | EP1265904B1 Novel positive allosteric ampa receptor modulators (paarm), method for the production and use thereof as medicaments |
| 09/22/2004 | EP1261335A4 Brain, spinal and nerve injury treatment |
| 09/22/2004 | EP1259495B1 Indane derivatives and their use as cell adhesion inhibitors |
| 09/22/2004 | EP1242073B1 Compositions for prevention and treatment of cold and influenza-like symptoms and their methods of use |
| 09/22/2004 | EP1235835A4 Chromium-histidine complexes as nutrient supplements |
| 09/22/2004 | EP1228056B1 Method for the preparation of citalopram |
| 09/22/2004 | EP1227096B1 4-oxoquinolizine antimicrobials having 2-pyridone skeletons as the partial structure |
| 09/22/2004 | EP1224206B1 Sapogenin derivatives and their use in the treatment of cognitive dysfunction |
| 09/22/2004 | EP1223916B1 Neutral-cationic lipid for nucleic acid and drug delivery |
| 09/22/2004 | EP1222187B1 Heterocyclic compounds useful as inhibitors of tyrosine kinases |
| 09/22/2004 | EP1207859B1 Oral form of administration containing probiotic micro-organisms |
| 09/22/2004 | EP1201678B1 Novel bicyclonucleoside analogues |
| 09/22/2004 | EP1200438B1 Method for making debromohymenialdisine and analogs thereof |
| 09/22/2004 | EP1196428B1 11-beta-aryl-17,17-spirothiolane-substituted steroids |
| 09/22/2004 | EP1192165B1 Substituted heterocycle fused gamma-carbolines |
| 09/22/2004 | EP1189904B1 Substituted heterocycle fused gamma-carbolines |
| 09/22/2004 | EP1187629B1 Adjuvant composition comprising saponin and an immunostimulatory oligonucleotide |
| 09/22/2004 | EP1169320B1 Farnesyl transferase inhibitors having a pyrrole structure and process for preparation thereof |
| 09/22/2004 | EP1163200B1 Method of industrial-scale purification of lactic acid |
| 09/22/2004 | EP1153014B1 Beta-alanine derivatives |
| 09/22/2004 | EP1152743B1 Skin sanitizing compositions |
| 09/22/2004 | EP1146874B1 Vitronectin receptor antagonist |
| 09/22/2004 | EP1144402B1 Substituted oximes and hydrazones as neurokinin antagonists |
| 09/22/2004 | EP1141251A4 Compounds, methods of screening and methods of treatment for central and peripheral nervous system disorders |
| 09/22/2004 | EP1140860B1 Pyrimidine compounds |
| 09/22/2004 | EP1135161B1 Chemotherapeutic composition and method |
| 09/22/2004 | EP1124820B1 Lipoic acid derivatives and their use in treatment of disease |
| 09/22/2004 | EP1124801B1 Piperidine and pyrrolidine derivatives comprising a nitric oxide donor for treating stress |
| 09/22/2004 | EP1100781B1 High affinity ligands for nociceptin receptor orl-1 |
| 09/22/2004 | EP1100503B1 Non-imidazole alkylamines as histamine h 3?-receptor ligands and their therapeutic applications |
| 09/22/2004 | EP1100407A4 Composition for freshening nostrils and sinus cavities |
| 09/22/2004 | EP1098646B1 Stabilized carvedilol injection solution |
| 09/22/2004 | EP1093455B1 Bis-indole derivatives and their use as antiinflammatory agents |
| 09/22/2004 | EP1077950B1 Novel diphenyl-substituted 6-ring-heterocycles, methods for producing them and their use as medicaments |
| 09/22/2004 | EP1064950B1 Remedies for hepatitis |
| 09/22/2004 | EP1060174B1 Nitric oxide releasing chelating agents and their therapeutic use |
| 09/22/2004 | EP1054869B1 3,4-dihydroquinoline derivatives as nitrogen monoxide synthase (nos) inhibitors |
| 09/22/2004 | EP1042340B1 6-o-alkyl erythromycin b oxime |
| 09/22/2004 | EP1040112B1 Imidazonaphthyridines and their use in inducing cytokine biosynthesis |
| 09/22/2004 | EP1030841B1 Process for the preparation of 1,4-dihydropyridines and compounds used in this process |
| 09/22/2004 | EP1012164B1 Serine protease inhibitors |
| 09/22/2004 | EP1007691B1 Methods and compositions for synthesis of long chain polyunsaturated fatty acids |
| 09/22/2004 | EP1001750B1 Stable particulate complexes with neutral or negative globale charge of lamellar structure |
| 09/22/2004 | EP1000062B1 Tricyclic vasopressin agonists |
| 09/22/2004 | EP0984786B1 Use of low-molecular-weight heparins for preventing and treating central nervous system trauma |
| 09/22/2004 | EP0975774B1 Bacterial plasmids |
| 09/22/2004 | EP0967969B1 Novel antioxidant mixture |
| 09/22/2004 | EP0957173B1 Process for preparing fat or oil containing unsaturated fatty acid |
| 09/22/2004 | EP0941121B1 Stable lyophilized pharmaceutical substances from monoclonal or polyclonal antibodies |
| 09/22/2004 | EP0914119B1 Process for forming solid oral dosage forms of valsartan |
| 09/22/2004 | EP0879231B1 Dihydrobenzofuran and related compounds useful as anti-inflammatory agents |
| 09/22/2004 | EP0866800B1 Antineoplastic peptides |
| 09/22/2004 | EP0841900B1 Pharmaceutical composition for detecting lung disease |
| 09/22/2004 | EP0831767B1 Alpha hydroxyacid esters for skin aging |
| 09/22/2004 | EP0830347B1 Novel substituted piperazine derivatives having tachykinin receptor antagonists activity |
| 09/22/2004 | EP0768895B1 Camptothecin drug combinations and medicaments with reduced side effects |
| 09/22/2004 | EP0768885B1 Method for inhibiting cancer metastasis by oral administration of soluble modified citrus pectin |
| 09/22/2004 | EP0706575B1 Retroviral vectors for transducing beta-globin gene and beta-locus control region derivatives |
| 09/22/2004 | EP0706524B1 Processes and intermediates for the preparation of 5- 2-(4-(benzoisothiazol-3-yl)-piperazin-1-yl)ethyl]-6-chloro-1,3-dihydro-indol-2-one |
| 09/22/2004 | EP0623133B1 Substituted amino alkyl compounds |
| 09/22/2004 | CN1531653A Method for identification of proteins from intracellular bacteria |
| 09/22/2004 | CN1531600A New polynucleotides and polypeptides of IFN 2-21 gene |
| 09/22/2004 | CN1531566A Positively charged amphiphilic block copolymer as drug carrier and complex thereof with negatively charged drug |
| 09/22/2004 | CN1531555A Glycosaminoglycans derived from K5 polysaccharide having high antithrombin activity and process for their preparation |
| 09/22/2004 | CN1531549A Pharmaceutical use for secreted bacterial effector proteins |
| 09/22/2004 | CN1531546A Peptide compounds |
| 09/22/2004 | CN1531543A Synthetic derivatives of 21-butenyl and related spinosyns |
| 09/22/2004 | CN1531538A 4-amino-5-phenyl-7-cyclobutyl-pyrrolo (2,3-D) pyrimidie derivatives |
| 09/22/2004 | CN1531537A Novel tricyclic pyridyl benzazepine carboxyamides and derivatives their tocolytic oxytocin leceptor antagonists |
| 09/22/2004 | CN1531536A Process for preparation of pyrazolo[4,3-D] pyrimidine derivative |